img

Global Nimodipine Sustained Release Tablets Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nimodipine Sustained Release Tablets Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Nimodipine sustained-release tablets are calcium antagonists, used for cerebral vasospasm and sudden deafness caused by ischemic cerebrovascular disease, migraine, mild subarachnoid hemorrhage. It can reduce the pain of vascular, tension, cluster and mixed headaches, reduce the frequency of attacks, and prevent the appearance of aura symptoms.
Nimodipine Sustained Release Tablets report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nimodipine Sustained Release Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nimodipine Sustained Release Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nimodipine Sustained Release Tablets key manufacturers include Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International, Heritage Pharmaceuticals, Bayer Vital, Wuhan HITECK Biopharmaceutical, Qilu Pharmaceutical and Yabao Pharmaceutical Group, etc. Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Nimodipine Sustained Release Tablets can be divided into 30mg/Piece, 60mg/Piece and Others,, etc. 30mg/Piece is the mainstream product in the market, accounting for % sales share globally in 2022.
Nimodipine Sustained Release Tablets is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Nimodipine Sustained Release Tablets industry development. In 2022, global % sales of Nimodipine Sustained Release Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nimodipine Sustained Release Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bionpharma
Arbor Pharmaceuticals
Sofgen Pharmaceuticals
Pharmaceutics International
Heritage Pharmaceuticals
Bayer Vital
Wuhan HITECK Biopharmaceutical
Qilu Pharmaceutical
Yabao Pharmaceutical Group
Sihuan Pharmaceutical
Jiangsu Kanion Pharmaceutical
Shandong Yunmen Pharmaceutical
Segment by Type
30mg/Piece
60mg/Piece
Others

Segment by Application


Hospital
Pharmacy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nimodipine Sustained Release Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nimodipine Sustained Release Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nimodipine Sustained Release Tablets industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Nimodipine Sustained Release Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nimodipine Sustained Release Tablets introduction, etc. Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Nimodipine Sustained Release Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Nimodipine Sustained Release Tablets Market Overview
1.1 Nimodipine Sustained Release Tablets Product Overview
1.2 Nimodipine Sustained Release Tablets Market Segment by Type
1.2.1 30mg/Piece
1.2.2 60mg/Piece
1.2.3 Others
1.3 Global Nimodipine Sustained Release Tablets Market Size by Type
1.3.1 Global Nimodipine Sustained Release Tablets Market Size Overview by Type (2024-2034)
1.3.2 Global Nimodipine Sustained Release Tablets Historic Market Size Review by Type (2024-2024)
1.3.3 Global Nimodipine Sustained Release Tablets Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nimodipine Sustained Release Tablets Sales Breakdown by Type (2024-2024)
1.4.2 Europe Nimodipine Sustained Release Tablets Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Nimodipine Sustained Release Tablets Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Nimodipine Sustained Release Tablets Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Nimodipine Sustained Release Tablets Sales Breakdown by Type (2024-2024)
2 Global Nimodipine Sustained Release Tablets Market Competition by Company
2.1 Global Top Players by Nimodipine Sustained Release Tablets Sales (2024-2024)
2.2 Global Top Players by Nimodipine Sustained Release Tablets Revenue (2024-2024)
2.3 Global Top Players by Nimodipine Sustained Release Tablets Price (2024-2024)
2.4 Global Top Manufacturers Nimodipine Sustained Release Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nimodipine Sustained Release Tablets Market Competitive Situation and Trends
2.5.1 Nimodipine Sustained Release Tablets Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nimodipine Sustained Release Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine Sustained Release Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Nimodipine Sustained Release Tablets Market
2.8 Key Manufacturers Nimodipine Sustained Release Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nimodipine Sustained Release Tablets Status and Outlook by Region
3.1 Global Nimodipine Sustained Release Tablets Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Nimodipine Sustained Release Tablets Historic Market Size by Region
3.2.1 Global Nimodipine Sustained Release Tablets Sales in Volume by Region (2024-2024)
3.2.2 Global Nimodipine Sustained Release Tablets Sales in Value by Region (2024-2024)
3.2.3 Global Nimodipine Sustained Release Tablets Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Nimodipine Sustained Release Tablets Forecasted Market Size by Region
3.3.1 Global Nimodipine Sustained Release Tablets Sales in Volume by Region (2024-2034)
3.3.2 Global Nimodipine Sustained Release Tablets Sales in Value by Region (2024-2034)
3.3.3 Global Nimodipine Sustained Release Tablets Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Nimodipine Sustained Release Tablets by Application
4.1 Nimodipine Sustained Release Tablets Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Others
4.2 Global Nimodipine Sustained Release Tablets Market Size by Application
4.2.1 Global Nimodipine Sustained Release Tablets Market Size Overview by Application (2024-2034)
4.2.2 Global Nimodipine Sustained Release Tablets Historic Market Size Review by Application (2024-2024)
4.2.3 Global Nimodipine Sustained Release Tablets Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nimodipine Sustained Release Tablets Sales Breakdown by Application (2024-2024)
4.3.2 Europe Nimodipine Sustained Release Tablets Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Nimodipine Sustained Release Tablets Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Nimodipine Sustained Release Tablets Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Nimodipine Sustained Release Tablets Sales Breakdown by Application (2024-2024)
5 North America Nimodipine Sustained Release Tablets by Country
5.1 North America Nimodipine Sustained Release Tablets Historic Market Size by Country
5.1.1 North America Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2024)
5.1.3 North America Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2024)
5.2 North America Nimodipine Sustained Release Tablets Forecasted Market Size by Country
5.2.1 North America Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2034)
5.2.2 North America Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2034)
6 Europe Nimodipine Sustained Release Tablets by Country
6.1 Europe Nimodipine Sustained Release Tablets Historic Market Size by Country
6.1.1 Europe Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2024)
6.1.3 Europe Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2024)
6.2 Europe Nimodipine Sustained Release Tablets Forecasted Market Size by Country
6.2.1 Europe Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2034)
6.2.2 Europe Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2034)
7 Asia-Pacific Nimodipine Sustained Release Tablets by Region
7.1 Asia-Pacific Nimodipine Sustained Release Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Nimodipine Sustained Release Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Value by Region (2024-2034)
8 Latin America Nimodipine Sustained Release Tablets by Country
8.1 Latin America Nimodipine Sustained Release Tablets Historic Market Size by Country
8.1.1 Latin America Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2024)
8.1.3 Latin America Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2024)
8.2 Latin America Nimodipine Sustained Release Tablets Forecasted Market Size by Country
8.2.1 Latin America Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2034)
8.2.2 Latin America Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2034)
9 Middle East and Africa Nimodipine Sustained Release Tablets by Country
9.1 Middle East and Africa Nimodipine Sustained Release Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Nimodipine Sustained Release Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bionpharma
10.1.1 Bionpharma Company Information
10.1.2 Bionpharma Introduction and Business Overview
10.1.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bionpharma Nimodipine Sustained Release Tablets Products Offered
10.1.5 Bionpharma Recent Development
10.2 Arbor Pharmaceuticals
10.2.1 Arbor Pharmaceuticals Company Information
10.2.2 Arbor Pharmaceuticals Introduction and Business Overview
10.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Products Offered
10.2.5 Arbor Pharmaceuticals Recent Development
10.3 Sofgen Pharmaceuticals
10.3.1 Sofgen Pharmaceuticals Company Information
10.3.2 Sofgen Pharmaceuticals Introduction and Business Overview
10.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Products Offered
10.3.5 Sofgen Pharmaceuticals Recent Development
10.4 Pharmaceutics International
10.4.1 Pharmaceutics International Company Information
10.4.2 Pharmaceutics International Introduction and Business Overview
10.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Pharmaceutics International Nimodipine Sustained Release Tablets Products Offered
10.4.5 Pharmaceutics International Recent Development
10.5 Heritage Pharmaceuticals
10.5.1 Heritage Pharmaceuticals Company Information
10.5.2 Heritage Pharmaceuticals Introduction and Business Overview
10.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Products Offered
10.5.5 Heritage Pharmaceuticals Recent Development
10.6 Bayer Vital
10.6.1 Bayer Vital Company Information
10.6.2 Bayer Vital Introduction and Business Overview
10.6.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Bayer Vital Nimodipine Sustained Release Tablets Products Offered
10.6.5 Bayer Vital Recent Development
10.7 Wuhan HITECK Biopharmaceutical
10.7.1 Wuhan HITECK Biopharmaceutical Company Information
10.7.2 Wuhan HITECK Biopharmaceutical Introduction and Business Overview
10.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Products Offered
10.7.5 Wuhan HITECK Biopharmaceutical Recent Development
10.8 Qilu Pharmaceutical
10.8.1 Qilu Pharmaceutical Company Information
10.8.2 Qilu Pharmaceutical Introduction and Business Overview
10.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Products Offered
10.8.5 Qilu Pharmaceutical Recent Development
10.9 Yabao Pharmaceutical Group
10.9.1 Yabao Pharmaceutical Group Company Information
10.9.2 Yabao Pharmaceutical Group Introduction and Business Overview
10.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Products Offered
10.9.5 Yabao Pharmaceutical Group Recent Development
10.10 Sihuan Pharmaceutical
10.10.1 Sihuan Pharmaceutical Company Information
10.10.2 Sihuan Pharmaceutical Introduction and Business Overview
10.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Products Offered
10.10.5 Sihuan Pharmaceutical Recent Development
10.11 Jiangsu Kanion Pharmaceutical
10.11.1 Jiangsu Kanion Pharmaceutical Company Information
10.11.2 Jiangsu Kanion Pharmaceutical Introduction and Business Overview
10.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Products Offered
10.11.5 Jiangsu Kanion Pharmaceutical Recent Development
10.12 Shandong Yunmen Pharmaceutical
10.12.1 Shandong Yunmen Pharmaceutical Company Information
10.12.2 Shandong Yunmen Pharmaceutical Introduction and Business Overview
10.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Products Offered
10.12.5 Shandong Yunmen Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nimodipine Sustained Release Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nimodipine Sustained Release Tablets Industrial Chain Analysis
11.4 Nimodipine Sustained Release Tablets Market Dynamics
11.4.1 Nimodipine Sustained Release Tablets Industry Trends
11.4.2 Nimodipine Sustained Release Tablets Market Drivers
11.4.3 Nimodipine Sustained Release Tablets Market Challenges
11.4.4 Nimodipine Sustained Release Tablets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nimodipine Sustained Release Tablets Distributors
12.3 Nimodipine Sustained Release Tablets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 30mg/Piece
Table 2. Major Company of 60mg/Piece
Table 3. Major Company of Others
Table 4. Global Nimodipine Sustained Release Tablets Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (K Units)
Table 6. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (US& Million)
Table 8. Global Nimodipine Sustained Release Tablets Market Share in Value by Type (2024-2024)
Table 9. Global Nimodipine Sustained Release Tablets Price by Type (2024-2024) & (USD/Unit)
Table 10. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2034) & (K Units)
Table 11. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Type (2024-2034)
Table 14. Global Nimodipine Sustained Release Tablets Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (K Units)
Table 16. North America Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Nimodipine Sustained Release Tablets Sales (K Units) by Type (2024-2024)
Table 18. Europe Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Nimodipine Sustained Release Tablets Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Nimodipine Sustained Release Tablets Sales (K Units) by Type (2024-2024)
Table 22. Latin America Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Nimodipine Sustained Release Tablets Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Nimodipine Sustained Release Tablets Sales by Company (2024-2024) & (K Units)
Table 26. Global Nimodipine Sustained Release Tablets Sales Share by Company (2024-2024)
Table 27. Global Nimodipine Sustained Release Tablets Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Nimodipine Sustained Release Tablets Revenue Share by Company (2024-2024)
Table 29. Global Market Nimodipine Sustained Release Tablets Price by Company (2024-2024) & (USD/Unit)
Table 30. Global Nimodipine Sustained Release Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Nimodipine Sustained Release Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine Sustained Release Tablets as of 2022)
Table 33. Date of Key Manufacturers Enter into Nimodipine Sustained Release Tablets Market
Table 34. Key Manufacturers Nimodipine Sustained Release Tablets Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Nimodipine Sustained Release Tablets Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Nimodipine Sustained Release Tablets Sales by Region (2024-2024) & (K Units)
Table 38. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Nimodipine Sustained Release Tablets Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2024-2024)
Table 41. Global Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 42. Global Nimodipine Sustained Release Tablets Sales by Region (2024-2034) & (K Units)
Table 43. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Nimodipine Sustained Release Tablets Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2024-2034)
Table 46. Global Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Nimodipine Sustained Release Tablets Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (K Units)
Table 49. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Application (2024-2024)
Table 52. Global Nimodipine Sustained Release Tablets Price by Application (2024-2024) & (USD/Unit)
Table 53. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2034) & (K Units)
Table 54. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Application (2024-2034)
Table 57. Global Nimodipine Sustained Release Tablets Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Nimodipine Sustained Release Tablets Sales by Application (2024-2024) (K Units)
Table 59. North America Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Nimodipine Sustained Release Tablets Sales by Application (2024-2024) (K Units)
Table 61. Europe Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Nimodipine Sustained Release Tablets Sales by Application (2024-2024) (K Units)
Table 65. Latin America Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (K Units)
Table 69. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2024)
Table 72. North America Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (K Units)
Table 73. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (K Units)
Table 77. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (K Units)
Table 81. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2034)
Table 108. Bionpharma Company Information
Table 109. Bionpharma Introduction and Business Overview
Table 110. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 111. Bionpharma Nimodipine Sustained Release Tablets Product
Table 112. Bionpharma Recent Development
Table 113. Arbor Pharmaceuticals Company Information
Table 114. Arbor Pharmaceuticals Introduction and Business Overview
Table 115. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 116. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product
Table 117. Arbor Pharmaceuticals Recent Development
Table 118. Sofgen Pharmaceuticals Company Information
Table 119. Sofgen Pharmaceuticals Introduction and Business Overview
Table 120. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 121. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product
Table 122. Sofgen Pharmaceuticals Recent Development
Table 123. Pharmaceutics International Company Information
Table 124. Pharmaceutics International Introduction and Business Overview
Table 125. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 126. Pharmaceutics International Nimodipine Sustained Release Tablets Product
Table 127. Pharmaceutics International Recent Development
Table 128. Heritage Pharmaceuticals Company Information
Table 129. Heritage Pharmaceuticals Introduction and Business Overview
Table 130. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 131. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product
Table 132. Heritage Pharmaceuticals Recent Development
Table 133. Bayer Vital Company Information
Table 134. Bayer Vital Introduction and Business Overview
Table 135. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 136. Bayer Vital Nimodipine Sustained Release Tablets Product
Table 137. Bayer Vital Recent Development
Table 138. Wuhan HITECK Biopharmaceutical Company Information
Table 139. Wuhan HITECK Biopharmaceutical Introduction and Business Overview
Table 140. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 141. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product
Table 142. Wuhan HITECK Biopharmaceutical Recent Development
Table 143. Qilu Pharmaceutical Company Information
Table 144. Qilu Pharmaceutical Introduction and Business Overview
Table 145. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 146. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product
Table 147. Qilu Pharmaceutical Recent Development
Table 148. Yabao Pharmaceutical Group Company Information
Table 149. Yabao Pharmaceutical Group Introduction and Business Overview
Table 150. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 151. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product
Table 152. Yabao Pharmaceutical Group Recent Development
Table 153. Sihuan Pharmaceutical Company Information
Table 154. Sihuan Pharmaceutical Introduction and Business Overview
Table 155. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 156. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product
Table 157. Sihuan Pharmaceutical Recent Development
Table 158. Jiangsu Kanion Pharmaceutical Company Information
Table 159. Jiangsu Kanion Pharmaceutical Introduction and Business Overview
Table 160. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 161. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product
Table 162. Jiangsu Kanion Pharmaceutical Recent Development
Table 163. Shandong Yunmen Pharmaceutical Company Information
Table 164. Shandong Yunmen Pharmaceutical Introduction and Business Overview
Table 165. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 166. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product
Table 167. Shandong Yunmen Pharmaceutical Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Nimodipine Sustained Release Tablets Market Trends
Table 171. Nimodipine Sustained Release Tablets Market Drivers
Table 172. Nimodipine Sustained Release Tablets Market Challenges
Table 173. Nimodipine Sustained Release Tablets Market Restraints
Table 174. Nimodipine Sustained Release Tablets Distributors List
Table 175. Nimodipine Sustained Release Tablets Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Nimodipine Sustained Release Tablets Product Picture
Figure 2. Global Nimodipine Sustained Release Tablets Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nimodipine Sustained Release Tablets Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Nimodipine Sustained Release Tablets Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of 30mg/Piece
Figure 6. Global 30mg/Piece Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of 60mg/Piece
Figure 8. Global 60mg/Piece Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Type in 2022 & 2034
Figure 13. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022
Figure 14. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022
Figure 15. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022
Figure 16. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022
Figure 19. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Nimodipine Sustained Release Tablets Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Nimodipine Sustained Release Tablets Revenue in 2022
Figure 25. Nimodipine Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Pharmacy
Figure 29. Global Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Nimodipine Sustained Release Tablets Sales Market Share by Application in 2022 & 2034
Figure 34. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022
Figure 35. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022
Figure 36. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022
Figure 37. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022
Figure 40. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Nimodipine Sustained Release Tablets Manufacturing Cost Structure
Figure 45. Nimodipine Sustained Release Tablets Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries